Vistin Pharma ASA: Mandatory notification of trade

Magnus Tolleshaug, Chief Executive Officer in Vistin Pharma ASA, and a primary insider, has on 20'th of February 2026 purchased 30.000 shares in Vistin Pharma ASA at an average price of NOK 21,10 per share. Following this purchase Magnus Tolleshaug holds 105.000 shares in Vistin Pharma ASA.

Attachment

• Notification of trade_skjema - Magnus Tolleshaug

You May Also Be Interested In

• DeFi Has Started Chasing Real Assets
• US-Based Thermoforming and Pressure Forming Manufacturer, Kal Plastics, to Exhibit at Southern California Design-2-Part Show
• Trusted Collaboration: influenScout Launches an Influencer Marketing Platform Built Around Evidence